News Briefs: KFF Poll Finds Voter Awareness of IRA Drug Pricing Is Low but Improving

Most U.S. voters are unaware of the Medicare drug pricing provisions resulting from the Inflation Reduction Act, although awareness among older voters has improved since November. That’s according to a new KFF poll tracking voters’ perceptions of major health and entitlement programs and how they align with presidential candidates’ views. Of voters aged 65 and older, nearly half (48%) indicated awareness of drug price negotiation — compared with 36% in November — and 40% knew about the annual limit on Part D out-of-pocket prescription drug costs, up from 27% in November. Meanwhile, large shares of voters indicated support for extending some of the prescription drug provisions to all adults with private insurance, which President Joe Biden has proposed, reported KFF.

© 2024 MMIT
Lauren Flynn Kelly

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

Related Posts

charts
June 6

Aetna, Insurtechs Outpaced Medicare Advantage Peers in Quieter OEP

READ MORE
gavel-paperwork
June 6

FMO Lawsuits Could Delay Agent and Broker Compensation Rules

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
June 6

News Briefs: SCAN Wins Lawsuit Over 2024 Star Ratings Calculations

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today